11-119357286-T-A
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_004205.5(USP2):c.1631A>T(p.Tyr544Phe) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00115 in 1,613,432 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004205.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00110 AC: 167AN: 151620Hom.: 3 Cov.: 30 show subpopulations
GnomAD2 exomes AF: 0.000411 AC: 103AN: 250672 AF XY: 0.000398 show subpopulations
GnomAD4 exome AF: 0.00115 AC: 1686AN: 1461696Hom.: 1 Cov.: 40 AF XY: 0.00115 AC XY: 836AN XY: 727136 show subpopulations
GnomAD4 genome AF: 0.00110 AC: 167AN: 151736Hom.: 3 Cov.: 30 AF XY: 0.00101 AC XY: 75AN XY: 74166 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1631A>T (p.Y544F) alteration is located in exon 12 (coding exon 11) of the USP2 gene. This alteration results from a A to T substitution at nucleotide position 1631, causing the tyrosine (Y) at amino acid position 544 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at